Integra LifeSciences Publishes Its Inaugural ESG Report
September 29, 2022 08:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today issued its inaugural Environmental,...
Integra LifeSciences Announces Participation in Upcoming Investor Conferences
August 23, 2022 12:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in...
Integra LifeSciences Announces the Passing of Dr. Richard Caruso, Founder and Former Chairman and CEO
August 16, 2022 08:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that Dr. Richard Caruso,...
Integra LifeSciences Reports Second Quarter 2022 Financial Results
July 27, 2022 06:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences Appoints Renee Lo as Director
July 19, 2022 08:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Renee Lo...
Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022
July 01, 2022 16:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- )Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2022 financial...
Integra LifeSciences Reports First Quarter 2022 Financial Results
April 27, 2022 06:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences to Host First Quarter 2022 Financial Results Conference Call on April 27, 2022
April 01, 2022 08:08 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial...
Integra LifeSciences Launches NeuraGen® 3D Nerve Guide Matrix
March 22, 2022 08:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company and pioneers in nerve repair, today announced...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance
February 23, 2022 06:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...